Aarti Pharmalabs Q2 FY27 Results Published in Newspapers
NiveshIQ
NSE: AARTIPHARM · Healthcare
Aarti Pharmalabs Ltd.
₹888.80▲ ₹16.10 (+1.84%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on AARTIPHARM. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Aarti Pharmalabs Ltd.
Aarti Pharmalabs Limited is a specialty chemical manufacturer that produces active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives for the Indian and global markets. The company’s core revenue drivers include high-margin API sales across therapeutic areas such as cardiovascular, anti-asthmatic, anti-cancer, and anti-diabetic, as well as contract development and manufacturing services (CDMO) for drug substance projects. In Q2 FY27, Aarti Pharmalabs reported a 46.8% year‑on‑year revenue growth to ₹1,969 crore, driven largely by a 50% increase in CDMO bookings and a 30% rise in API sales volume. Net income for the quarter stood at ₹205 crore, reflecting improved operational efficiencies despite rising raw material costs. The firm’s competitive positio
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,853 Cr -4.76% | ₹2,115 Cr +14.17% | ₹1,819 Cr -13.98% |
| EBITDA Margin | 20.84% | 21.96% | 20.29% |
| Net Profit | ₹216.45 Cr +11.87% | ₹272.40 Cr +25.85% | ₹172.71 Cr -36.60% |
| EPS | ₹23.93 | ₹30.06 | ₹19.27 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Aarti Pharmalabs (NSE:AARTIPHARM) Announces Q2 FY27 Unaudited Financial Results Publication
AARTIPHARM: Record Q2 revenue and EBITDA underpin expansion, with CDMO growth tempered by cost and execution risks
🔒
+ 3 more stories about Aarti Pharmalabs Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹610 Cr, PAT ₹69 Cr, EPS ₹7.88, EBITDA margin 22.1%. Growth context: revenue YoY +45.9%, PAT YoY +141.3%, revenue QoQ +13.9%, PAT QoQ -9.5%.
Management highlights product launches, approvals, therapy‑mix improvement, new capacity addition and capex deployment a...
FY26 (last completed FY): revenue ₹1, 819 Cr, PAT ₹173 Cr, EBITDA margin 20.3%, EPS ₹19.27. Year-on-year: revenue YoY -1...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Vijaya Diagnostic Centre Ltd.Viyash Scientific Ltd.Wockhardt Ltd.Yatharth Hospital & Trauma Care Services Ltd.Zydus Lifesciences Ltd.Aarti Drugs Ltd.Abbott India Ltd.Acutaas Chemicals Ltd.Advanced Enzyme Tech Ltd.Ajanta Pharmaceuticals Ltd.Akums Drugs and Pharmaceuticals Ltd.Alembic Pharmaceuticals Ltd.
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for AARTIPHARM
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track AARTIPHARM alongside your other holdings
Unlock full AARTIPHARM research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Aarti Pharmalabs Ltd.?
NiveshIQ detects active intelligence signals for Aarti Pharmalabs Ltd. (AARTIPHARM) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Aarti Pharmalabs Ltd.?
Aarti Pharmalabs Ltd. operates in the Healthcare sector with a market capitalisation of ₹619,297.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.